Rosiptor, with the CAS number 782487-28-9, is a chemical compound that has been studied primarily for its potential therapeutic applications. It belongs to a class of substances known for their role in modulating biological pathways, particularly in the context of metabolic disorders. The compound exhibits properties that may influence lipid metabolism and glucose homeostasis, making it of interest in the treatment of conditions such as obesity and type 2 diabetes. Rosiptor's mechanism of action typically involves interactions with specific receptors or enzymes that regulate metabolic processes. As with many pharmaceutical compounds, its efficacy and safety profile are evaluated through clinical trials, which assess its pharmacokinetics, pharmacodynamics, and potential side effects. The compound's characteristics, including solubility, stability, and reactivity, are crucial for its formulation and delivery in therapeutic settings. Overall, Rosiptor represents a promising candidate in the ongoing research aimed at developing effective treatments for metabolic diseases.

Rosiptor

782487-28-9: Rosiptor, with the CAS number 782487-28-9, is a chemical compound that has been studied primarily for its potential therapeutic applications. It belongs to a class of substances known for their role in modulating biological pathways, particularly in the context of metabolic disorders. The compound exhibits properties that may influence lipid metabolism and glucose homeostasis, making it of interest in the treatment of conditions such as obesity and type 2 diabetes. Rosiptor's mechanism of action typically involves interactions with specific receptors or enzymes that regulate metabolic processes. As with many pharmaceutical compounds, its efficacy and safety profile are evaluated through clinical trials, which assess its pharmacokinetics, pharmacodynamics, and potential side effects. The compound's characteristics, including solubility, stability, and reactivity, are crucial for its formulation and delivery in therapeutic settings. Overall, Rosiptor represents a promising candidate in the ongoing research aimed at developing effective treatments for metabolic diseases.

Rosiptor (AQX-1125) (AQX-1125) is an orally-active and specific phosphatase SHIP1 activator with anti-inflammatory effects.

CAS 782487-28-9

Rosiptor

Rosiptor

Ref: IN-DA01EOEX

Rosiptor

Ref: 54-BUP01577

Rosiptor

Ref: TM-TQ0032